{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:11:40Z","timestamp":1789143100414,"version":"build-2803163510"},"reference-count":33,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2019,5,23]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> The management of complex perianal fistulas in Crohn\u2019s disease (CD) represents a\nchallenge for patients, gastroenterologists and colorectal surgeons. There are clear limitations with current medical\nand surgical options, and healing rates remain far from what is expected. A multidisciplinary approach with\noptimized medical therapy, usually anti-TNF agents, associated with setons and additional surgical techniques is\ncurrently the best strategy to aim fistula healing.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A comprehensive review of the literature was conducted on the use of mesenchymal stem cells\n(MSCs).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The use of mesenchymal stem cells (MSCs) has recently emerged as a promising new therapeutic strategy\nfor complex fistulas in CD patients. This review summarizes the evidence of the use of MSCs in complex CD\nfistulas, by exploring in detail the types of cells that can be used and their modes of delivery. Additionally, the\nresults of the most recent phase III randomized trial with local MSCs injection are described, and future challenges\nof this therapeutic option are discussed.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> The use of MSCs represents hope for better outcomes in patients with CD-related perianal fistulas.\nMore research in the field will help to position this specific therapy in treatment algorithms.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612825666190308095651","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T07:28:18Z","timestamp":1557818898000},"page":"41-46","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cell-based Therapy for Perianal Fistulising Crohn\u2019s Disease"],"prefix":"10.2174","volume":"25","author":[{"given":"Paulo Gustavo","family":"Kotze","sequence":"first","affiliation":[{"name":"Colorectal Surgery Unit, IBD outpatient clinics, Catholic University of Parana, Curitiba, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Spinelli","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Humanitas Clinical and Research Center, Rozzano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Lee","family":"Lightner","sequence":"additional","affiliation":[{"name":"Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"Schwartz D.A.","year":"2002","unstructured":"Schwartz DA, Loftus EV, Tremaine WJ.  The natural history of fistulizing Crohn\u2019s disease in Olmsted County, Minnesota.","journal-title":"Gastroenterology"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","volume":"125","author":"Sandborn W.J.","year":"2003","unstructured":"Sandborn WJ, Fazio VW, Feagan BG, Hanauer SB.  AGA technical review on perianal Crohn\u2019s disease.","journal-title":"Gastroenterology"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1590\/S0004-28032014000400004","volume":"51","author":"Kotze P.G.","year":"2014","unstructured":"Kotze PG, Albuquerque IC, da Luz Moreira A, Tonini WB, Olandoski M, Coy CS.  Perianal complete remission with combined therapy (seton placement and anti-TNF agents) in Crohn\u2019s disease: a Brazilian multicenter observational study.","journal-title":"Arq Gastroenterol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/gutjnl-2017-314918","volume":"67","author":"Kotze P.G.","year":"2018","unstructured":"Kotze PG, Shen B, Lightner A.  Modern management of perianal fistulas in Crohn\u2019s disease: Future directions.","journal-title":"Gut"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3727\/096368912X656045","volume":"22","author":"Cho Y.B.","year":"2013","unstructured":"Cho YB, Lee WY, Park KJ, Kim M, Yoo HW, Yu CS.  Autologous adipose tissue-derived stem cells for the treatment of Crohn\u2019s fistula: a phase I clinical study.","journal-title":"Cell Transplant"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2017.04.001","volume":"153","author":"Dietz A.B.","year":"2017","unstructured":"Dietz AB, Dozois EJ, Fletcher JG.  Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients With Crohn\u2019s Disease.","journal-title":"Gastroenterology"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","volume":"48","author":"Garc\u00eda-Olmo D.","year":"2005","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Herreros D, Pascual I, Peiro C, Rodr\u00edguez-Montes JA.  A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation.","journal-title":"Dis Colon Rectum"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","volume":"52","author":"Garcia-Olmo D.","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual I.  Expanded adipose-derived stem cells for the treatment of complex perianal fistula: A phase II clinical trial.","journal-title":"Dis Colon Rectum"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","volume":"149","author":"Molendijk I.","year":"2015","unstructured":"Molendijk I, Bonsing BA, Roelofs H.  Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease.","journal-title":"Gastroenterology"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5966\/sctm.2014-0199","volume":"4","author":"Cho Y.B.","year":"2015","unstructured":"Cho YB, Park KJ, Yoon SN.  Long-term results of adipose-derived stem cell therapy for the treatment of Crohn\u2019s fistula.","journal-title":"Stem Cells Transl Med"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","volume":"28","author":"de la Portilla F.","year":"2013","unstructured":"de la Portilla F, Alba F, Garc\u00eda-Olmo D, Herrer\u00edas JM, Gonz\u00e1lez FX, Galindo A.  Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn\u2019s disease: results from a multicenter phase I\/IIa clinical trial.","journal-title":"Int J Colorectal Dis"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"Pan\u00e9s J.","year":"2016","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G.  Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial.","journal-title":"Lancet"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","volume":"60","author":"Ciccocioppo R.","year":"2011","unstructured":"Ciccocioppo R, Bernardo ME, Sgarella A.  Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn\u2019s disease.","journal-title":"Gut"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00384-003-0490-3","volume":"18","author":"Garc\u00eda-Olmo D.","year":"2003","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Garc\u00eda LG.  Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn\u2019s disease: a new cell-based therapy.","journal-title":"Int J Colorectal Dis"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/stem.1357","volume":"31","author":"Lee W.Y.","year":"2013","unstructured":"Lee WY, Park KJ, Cho YB.  Autologous adipose tissue-derived stem cells treatment demonstrated favorable and sustainable therapeutic effect for Crohn\u2019s fistula.","journal-title":"Stem Cells"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jcyt.2013.04.010","volume":"15","author":"Lo Surdo J.L.","year":"2013","unstructured":"Lo Surdo JL, Millis BA, Bauer SR.  Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells.","journal-title":"Cytotherapy"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"e0164269","DOI":"10.1371\/journal.pone.0164269","volume":"11","author":"Sammour I.","year":"2016","unstructured":"Sammour I, Somashekar S, Huang J.  The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.","journal-title":"PLoS One"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.stemcr.2017.07.014","volume":"9","author":"Serena C.","year":"2017","unstructured":"Serena C, Keiran N, Madeira A.  Crohn\u2019s Disease Disturbs the Immune Properties of Human Adipose-Derived Stem Cells Related to Inflammasome Activation.","journal-title":"Stem Cell Reports"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cellimm.2015.01.002","volume":"293","author":"Gharibi T.","year":"2015","unstructured":"Gharibi T, Ahmadi M, Seyfizadeh N, Jadidi-Niaragh F, Yousefi M.  Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.","journal-title":"Cell Immunol"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1089\/scd.2013.0554","volume":"23","author":"Kimbrel E.A.","year":"2014","unstructured":"Kimbrel EA, Kouris NA, Yavanian GJ.  Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties.","journal-title":"Stem Cells Dev"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"Ankrum J.A.","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM.  Mesenchymal stem cells: immune evasive, not immune privileged.","journal-title":"Nat Biotechnol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"Hare J.M.","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G.  Comparison of allogeneic  autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.","journal-title":"JAMA"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13287-015-0053-x","volume":"6","author":"Pezzanite L.M.","year":"2015","unstructured":"Pezzanite LM, Fortier LA, Antczak DF.  Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses","journal-title":"Stem Cell Res Ther"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/ndt\/gfm740","volume":"23","author":"Comoli P.","year":"2008","unstructured":"Comoli P, Ginevri F, Maccario R.  Human mesenchymal stem cells inhibit antibody production induced  by allostimulation.","journal-title":"Nephrol Dial Transplant"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.exphem.2010.06.011","volume":"38","author":"Isakova I.A.","year":"2010","unstructured":"Isakova IA, Dufour J, Lanclos C, Bruhn J, Phinney DG.  Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs.","journal-title":"Exp Hematol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"e87238","DOI":"10.1371\/journal.pone.0087238","volume":"9","author":"Isakova I.A.","year":"2014","unstructured":"Isakova IA, Lanclos C, Bruhn J.  Allo-reactivity of mesenchymal stem cells in rhesus macaques is dose and haplotype dependent and limits durable cell engraftment","journal-title":"PLoS One"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.tp.0000258649.23081.a3","volume":"83","author":"Poncelet A.J.","year":"2007","unstructured":"Poncelet AJ, Vercruysse J, Saliez A, Gianello P.  Although pig allogeneic mesenchymal stem cells are not immunogenic , intracardiac injection elicits an immune response","journal-title":"Transplantation"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"Trounson A.","year":"2015","unstructured":"Trounson A, McDonald C.  Stem cell therapies in clinical trials: Progress and challenges.","journal-title":"Cell Stem Cell"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/icb.2012.64","volume":"91","author":"Jacobs S.A.","year":"2013","unstructured":"Jacobs SA, Roobrouck VD, Verfaillie CM, Van Gool SW.  Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells.","journal-title":"Immunol Cell Biol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ebiom.2018.01.002","volume":"28","author":"Kim D.S.","year":"2018","unstructured":"Kim DS, Jang IK, Lee MW.  Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-\u03b3.","journal-title":"EBioMedicine"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1089\/ten.tea.2012.0665","volume":"19","author":"Kim I.","year":"2013","unstructured":"Kim I, Lee SK, Yoon JI, Kim DE, Kim M, Ha H.  Fibrin glue improves the therapeutic effect of MSCs by sustaining survival and paracrine function.","journal-title":"Tissue Eng Part A"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"Pan\u00e9s J.","year":"2018","unstructured":"Pan\u00e9s J, Garc\u00eda-Olmo D, Van Assche G.  Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn\u2019s Disease.","journal-title":"Gastroenterology"},{"key":"ref=33"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T09:14:25Z","timestamp":1564046065000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170556\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,5,23]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612825666190308095651","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,23]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}